Header Logo

Connection

JOHN VIERLING to Uridine Monophosphate

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about Uridine Monophosphate.
JOHN VIERLING
Connection Strength
0.101
Uridine Monophosphate
  1. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial. Lancet. 2013 Jun 15; 381(9883):2100-7.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.